Colchicine and Prevention of Cardiovascular Events.
Is continuous long-term treatment with colchicine associated with lower rates of all-cause mortality and myocardial infarction and higher rates of adverse events?



Continuous long-term treatment with colchicine may be associated with lower rates of myocardial infarction, but may be associated with higher rates of gastrointestinal adverse events.
Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, Switzerland.
Lars G
LG
Hemkens
Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, Switzerland.
Hannah
H
Ewald
Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, Switzerland2Department of Clinical Research, University of Basel, Basel, Switzerland3Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
Matthias
M
Briel
D003078:Colchicine; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*
D003078:Colchicine